Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

12
CompanyDrug NameStatusIndication Group
Lilly Zyprexa Approved in USANervous system
Lilly Yentreve Approved in EUGenito urinary system & sex hormones
Lilly Symbyax Approved in USANervous system
Lilly Strattera Approved in USA and EUNervous system
Lilly Humalog Approved in USAAlimentary tract & metabolism
Lilly Gemzar and Taxol accomplished Phase IIIAntineoplastic & immunomodulating agents
Lilly Gemzar Approved in USAAntineoplastic & immunomodulating agents
Lilly Evista Approved in USAMusculoskeletal system
Lilly Cymbalta Approved in USANervous system
Lilly Cymbalta Approved in EU and USANervous system
Lilly BYETTA Approved in USA and EUAlimentary tract & metabolism
Lilly ALIMTA accomplished Phase IIAntineoplastic & immunomodulating agents
Lilly No drug name Approved in USACardiovascular system
Lilly No drug name in Phase IICardiovascular system
Lilly No drug name in Phase IINervous system
Lilly No drug name accomplished Phase IIGenito urinary system & sex hormones
Lilly No drug name in Phase ICardiovascular system
Lilly No drug name discontinuedRespiratory system
Lilly No drug name accomplished Phase IIICardiovascular system
Lilly No drug name accomplished Phase IIAlimentary tract & metabolism
12




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.